| Identification | |
| Name: | (o-BROMOBENZYL)ETHYLDIMETHYL AMMONIUM-p-TOLUENESULFONATE |
| Synonyms: | bretyliumtosilate;2bromobenzylethyldimethylammoniumtoluene4sulphonate;2'Deoxy2',2'difluorocytidine;Bretylol |
| CAS: | 61-75-6 |
| EINECS: | 200-516-8 |
| Molecular Formula: | C11H17BrN•C7H7O3S |
| Molecular Weight: | 414.36 |
| InChI: | InChI=1/C11H17BrN.C7H8O3S/c1-4-13(2,3)9-10-5-7-11(12)8-6-10;1-6-2-4-7(5-3-6)11(8,9)10/h5-8H,4,9H2,1-3H3;2-5H,1H3,(H,8,9,10)/q+1;/p-1 |
| Molecular Structure: |  |
| Properties | |
| Specification: | usageEng:Bretylium tosylate has a biphasic response, initially inducing norepinephrine release followed by sympathetic ganglionic blockade. Bretylium tosylate is a class III antiarrhythmic agent and a competitive inhibitor of acetylcholinesterase. Safety Statements:36 36:Wear suitable protective clothing |
| Usage: | Bretylium tosylate has a biphasic response, initially inducing norepinephrine release followed by sympathetic ganglionic blockade. Bretylium tosylate is a class III antiarrhythmic agent and a competitive inhibitor of acetylcholinesterase. |
| Safety Data | |
 |
|
